Overview

A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This is a vehicle and comparator controlled Proof of Mechanism (PoM) trial to evaluate the effect on psoriasis disease activity and safety of topically applied PF 06263276 in subjects with psoriasis vulgaris.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Calcipotriene
Calcitriol
Tofacitinib